Insider · CIK 0001748691
Mark Kaye
Files at CNMD (CONMED Corp), ELV (Elevance Health, Inc.). First filing Apr 25, 2025, latest Apr 25, 2025.
Mark Kaye files SEC Form 4 as director and CFO at ELV (Elevance Health, Inc.), and also at CNMD (CONMED Corp). Since Apr 25, 2025, Mark Kaye has reported 0 open-market buys worth $0 and 1 open-market sell worth $1.9M, the latest filed on Apr 25, 2025.
A track record needs three past buys with six months of prices behind them; Mark Kaye has 0, so none is measured yet.
The newest scored trade: sold $1.9M of ELV on Apr 24, 2025, filed Apr 25, 2025, scored 52 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ELV: Elevance Health, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 52Moderate | ELVsell Elevance Health, Inc. | $1.9M 4,588 shares | -19% | +18% from low-22% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Apr 24, 2025 | ELV Elevance Health, Inc. | 4,588 0.00% of outstanding | $1.9M | Apr 24, 2025 | none |
Transactions
Every row this insider has filed, 21 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 2, 2026 | ELV Elevance Health, Inc. | FTax withholding Common Stock | -4,161 | $386.43 | $1.6M | 27,876 | 7 d ago |
| Oct 2, 2026 | ELV Elevance Health, Inc. | AGrant or award Common Stock | +2,627 | $0.00 | $0 | 30,503 | 7 d ago |
| Jun 2, 2026 | CNMD CONMED Corp | MOption exercise Common Stock | +668 | $0.00 | $0 | 820 | Jun 3, 2026 |
| Jun 1, 2026 | CNMD CONMED Corp | AGrant or award RSUs (Restricted Stock Units)derivative | +5,772 | $0.00 | $0 | 5,772 | Jun 3, 2026 |
| Jun 2, 2026 | CNMD CONMED Corp | MOption exercise RSUs (Restricted Stock Units)derivative | -668 | $0.00 | $0 | 0 | Jun 3, 2026 |
| Mar 2, 2026 | ELV Elevance Health, Inc. | FTax withholding Common Stock | -271 | $294.07 | $80k | 15,811 | Mar 4, 2026 |
| Mar 2, 2026 | ELV Elevance Health, Inc. | AGrant or award Common Stock | +6,377 | $0.00 | $0 | 22,188 | Mar 4, 2026 |
| Mar 2, 2026 | ELV Elevance Health, Inc. | AGrant or award Common Stock | +10,202 | $0.00 | $0 | 32,390 | Mar 4, 2026 |
| Mar 3, 2026 | ELV Elevance Health, Inc. | FTax withholding Common Stock | -353 | $284.03 | $100k | 32,037 | Mar 4, 2026 |
| Mar 2, 2026 | ELV Elevance Health, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +25,188 | $0.00 | $0 | 25,188 | Mar 4, 2026 |
| Feb 24, 2026 | CNMD CONMED Corp | MOption exercise Common Stock | +152 | $0.00 | $0 | 152 | Feb 26, 2026 |
| Feb 24, 2026 | CNMD CONMED Corp | MOption exercise RSUs (Restricted Stock Units)derivative | -152 | $0.00 | $0 | 0 | Feb 26, 2026 |
| Oct 2, 2025 | ELV Elevance Health, Inc. | FTax withholding Common Stock | -2,895 | $340.24 | $985k | 16,082 | Oct 3, 2025 |
| Jun 2, 2025 | CNMD CONMED Corp | AGrant or award Options To Purchase Common Stockderivative | +8,061 | $0.00 | $0 | 8,061 | Jun 4, 2025 |
| Jun 2, 2025 | CNMD CONMED Corp | AGrant or award RSUs (Restricted Stock Units)derivative | +668 | $0.00 | $0 | 668 | Jun 4, 2025 |
| Apr 24, 2025 | ELV Elevance Health, Inc. | SOpen-market sale Common Stock | -4,588 | $424.82 | $1.9M | 18,977 | Apr 25, 2025 |
| Mar 3, 2025 | ELV Elevance Health, Inc. | FTax withholding Common Stock | -270 | $395.50 | $107k | 19,961 | Mar 5, 2025 |
| Mar 3, 2025 | ELV Elevance Health, Inc. | AGrant or award Common Stock | +3,604 | $0.00 | $0 | 23,565 | Mar 5, 2025 |
| Mar 3, 2025 | ELV Elevance Health, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +13,713 | $0.00 | $0 | 13,713 | Mar 5, 2025 |
| Feb 24, 2025 | CNMD CONMED Corp | AGrant or award Options To Purchase Common Stockderivative | +1,846 | $0.00 | $0 | 1,846 | Feb 26, 2025 |
| Feb 24, 2025 | CNMD CONMED Corp | AGrant or award RSUs (Restricted Stock Units)derivative | +152 | $0.00 | $0 | 152 | Feb 26, 2025 |
Questions about Mark Kaye
Answered from the filings on this page, as of the latest one.
Is Mark Kaye buying or selling?
Not in the last 12 months. Mark Kaye's latest open-market trade on SEC Form 4 was sold $1.9M of ELV on Apr 24, 2025.
How did Mark Kaye's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Mark Kaye has 0.
Where does Mark Kaye file Form 4?
Mark Kaye has filed Form 4 at ELV (Elevance Health, Inc.) as EVP & CFO; CNMD (CONMED Corp). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.